Advertisement
UK markets open in 2 hours 12 minutes
  • NIKKEI 225

    37,691.83
    -768.25 (-2.00%)
     
  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     
  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     
  • GOLD FUTURES

    2,325.30
    -13.10 (-0.56%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,593.14
    -2,027.34 (-3.78%)
     
  • CMC Crypto 200

    1,388.14
    -35.96 (-2.53%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

The 1 Stock I'd Buy Right Now

The 1 Stock I'd Buy Right Now

There were a lot of companies that jumped to action last year in the fight against the SARS-CoV-2 virus. In that latter category, one company proved it has a business model to succeed long after the pandemic ends -- assuming it ever does. Fulgent Genetics (NASDAQ: FLGT) burst onto the scene when the Food and Drug Administration (FDA) approved its test for detecting COVID-19 in June 2020.